Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults

Ads

You May Also Like

Aduro Biotech to Present at Two Upcoming Investor Conferences

BERKELEY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

BeiGene to Participate in 25th Annual Credit Suisse Healthcare Conference

WALTHAM, Mass., Nov. 01, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (Nasdaq:BGNE), a clinical-stage biopharmaceutical ...

Cempra to Report First Quarter 2016 Financial Results

CHAPEL HILL, N.C., April 25, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...